Awiqli (insulin icodec)
- Region
- 🇪🇺 EU
- Active substance
- insulin icodec
- Company
- Novo Nordisk A/S
- Status
- Authorised
- Therapeutic area
- Diabetes Mellitus; Diabetes Mellitus, Type 2
- CHMP opinion
- Thu 21 Mar 2024
- EU approval
- Fri 17 May 2024
- Application
- EMEA/H/C/005978
- ATC
- A10AE07
- Official record
- www.ema.europa.eu
Indication
Treatment of diabetes mellitus in adults
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇺🇸 Awiqli Flextouch Approved · Novo Nordisk Inc
- 🇪🇺 Kyinsu Authorised · Novo Nordisk A/S
Follow Awiqli
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.